Concepedia

C. Harvengt

CH

Statistics

Publications

41

Citations

995

H-Index

19

Active since

1970

Affiliations

UCLouvain(Current)

C. Harvengt is an author at UCLouvain specializing in pharmacology, clinical pharmacology, and medicine.

Publications per year

1970–2008

41

Publications

41

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

F. Heller, C. Harvengt · European Journal of Clinical Pharmacology · 1983 · 138 citations

, , +14

Pharmacodynamic activity of lipoprotein lipase and hepatic lipase, and pharmacokinetic parameters measured in normolipidaemic subjects receiving ciprofibrate (100 or 200 mg/day) or micronised fenofibrate (200 mg/day) therapy for 23 days

Jean‐Pierre Desager, Yves Horsmans, Catherine Vandenplas et al. · Atherosclerosis · 1996 · 55 citations

, , +17

Hypolipidemic and hypouricemic action of fenofibrate in various types of hyperlipoproteinemias.

C. Harvengt, F. Heller, Jean‐Pierre Desager · PubMed · 1980 · 44 citations

, , +16

Naproxen Plasma Levels in Volunteers After Single‐Dose Administration by Oral and Rectal Routes

J.P. Desager, M. Vanderbist, C. Harvengt · The Journal of Clinical Pharmacology · 1976 · 42 citations

, , +15

Absence of CYP3 A Genetic Polymorphism Assessed by Urinary Excretion of 6 β‐Hydroxycortisol in 102 Healthy Subjects on Rifampicin

Yves Horsmans, J.P. Desager, C. Harvengt · Pharmacology & Toxicology · 1992 · 41 citations

, , +13

1–5 of 41